Medical Developments (Australia) Price Prediction
| MVP Stock | 0.42 0.01 2.33% |
Oversold Vs Overbought
46
Oversold | Overbought |
Quarterly Earnings Growth (0.84) | Wall Street Target Price 2.94 | Quarterly Revenue Growth (0.02) |
Using Medical Developments hype-based prediction, you can estimate the value of Medical Developments International from the perspective of Medical Developments response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medical Developments to buy its stock at a price that has no basis in reality. In that case, they are not buying Medical because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medical Developments after-hype prediction price | AUD 0.42 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medical |
Medical Developments After-Hype Price Prediction Density Analysis
As far as predicting the price of Medical Developments at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medical Developments or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medical Developments, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medical Developments Estimiated After-Hype Price Volatility
In the context of predicting Medical Developments' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medical Developments' historical news coverage. Medical Developments' after-hype downside and upside margins for the prediction period are 0.02 and 3.72, respectively. We have considered Medical Developments' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medical Developments is out of control at this time. Analysis and calculation of next after-hype price of Medical Developments is based on 3 months time horizon.
Medical Developments Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medical Developments is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medical Developments backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medical Developments, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 3.27 | 0.00 | 0.00 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.42 | 0.42 | 0.00 |
|
Medical Developments Hype Timeline
Medical Developments is now traded for 0.42on Australian Securities Exchange of Australia. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medical is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.05%. %. The volatility of related hype on Medical Developments is about 15092.31%, with the expected price after the next announcement by competition of 0.42. About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medical Developments recorded a loss per share of 0.46. The entity last dividend was issued on the 5th of March 2020. Assuming the 90 days trading horizon the next projected press release will be very soon. Check out Medical Developments Basic Forecasting Models to cross-verify your projections.Medical Developments Related Hype Analysis
Having access to credible news sources related to Medical Developments' direct competition is more important than ever and may enhance your ability to predict Medical Developments' future price movements. Getting to know how Medical Developments' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medical Developments may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HTA | Hutchison Telecommunications | 0.00 | 0 per month | 3.50 | (0.02) | 4.00 | (9.09) | 31.55 | |
| QUE | Queste Communications | 0.00 | 2 per month | 0.00 | (0.65) | 0.00 | 0.00 | 2.00 | |
| GDF | Garda Diversified Ppty | 0.01 | 1 per month | 1.15 | 0.01 | 2.63 | (2.44) | 10.33 | |
| ARG | Argo Investments | (0.04) | 2 per month | 0.41 | (0.21) | 0.80 | (0.78) | 1.80 | |
| SNC | Sandon Capital Investments | 0.01 | 1 per month | 1.04 | 0.02 | 2.67 | (2.53) | 5.41 | |
| TPG | TPG Telecom | (0.11) | 2 per month | 0.00 | (0.09) | 2.01 | (1.66) | 12.35 |
Medical Developments Additional Predictive Modules
Most predictive techniques to examine Medical price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medical using various technical indicators. When you analyze Medical charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medical Developments Predictive Indicators
The successful prediction of Medical Developments stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medical Developments International, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medical Developments based on analysis of Medical Developments hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medical Developments's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medical Developments's related companies.
Story Coverage note for Medical Developments
The number of cover stories for Medical Developments depends on current market conditions and Medical Developments' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medical Developments is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medical Developments' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medical Developments Short Properties
Medical Developments' future price predictability will typically decrease when Medical Developments' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medical Developments International often depends not only on the future outlook of the potential Medical Developments' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medical Developments' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 88.6 M | |
| Cash And Short Term Investments | 9.7 M |
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.